Thirty-year life science veteran Philippa Marshall, M.D., has been hired as Worldwide Clinical Trials’ new vice president for scientific solutions in immune-mediated inflammatory disorders.
The North Carolina-based CRO takes on Marshall after a career spanning three decades, with stints at GlaxoSmithKline, Novo Nordisk, inVentiv Health and, more recently, PPD, where her roles focused predominately on immunology, rare diseases and medicines for kids.
“Dr. Marshall brings an unwavering dedication to advancing science and medicine and nearly three decades of therapeutic expertise to our expanding Scientific Solutions team,” said Peter Benton, president and chief operating officer of WCT.
RELATED: Worldwide Clinical inks partnership deal with Deep Lens
“She will play a key role in providing the innovative insight our customers have come to expect from a CRO of our size. There’s really no substitute for the uncommon combination of world-class therapeutic expertise, global operations and personalized attention our team delivers," Benton added.